Hansen Medical

What Hansen Medical does

Hansen Medical was a Mountain View, California-based medical robotics company founded in 2002 that designed and manufactured robotic systems for the precise positioning and control of catheter-based technologies. Its core product was the Magellan Robotic System, a robotic-assisted surgical platform developed for cardiovascular procedures, including robotic percutaneous coronary intervention (r-PCI), vascular interventions, and electrophysiology applications such as the diagnosis and treatment of atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. The system addressed limitations of manual catheter manipulation by enabling precise, minimally invasive cardiovascular interventions with enhanced catheter control and navigation, reduced radiation exposure to operators, and improved procedural accuracy.

Hansen Medical went public on NASDAQ under the ticker HNSN and raised approximately $115M across multiple equity rounds between 2005 and 2015 from investors including Oracle Investment Management, Westwood Holdings Group, Prospect Venture Partners, Skyline Ventures, and Vanguard Ventures. The company pursued an inorganic growth strategy, acquiring EndoVia Medical in 2005 to seed catheter robotics technology and AorTx in 2007 to broaden cardiovascular scope. Revenue was generated through capital equipment sales of robotic systems to hospitals and cardiovascular care centers, distributed through Philips' medical device channels following the 2019 acquisition. Pricing was not publicly disclosed.

In 2019, Hansen Medical was acquired by Philips and now operates as part of Philips' Image-Guided Therapy / medical robotics portfolio. The acquisition integrated the Magellan platform with Philips' broader medical imaging and intervention offering. Post-acquisition, the company does not maintain an independent web presence — the original HansenMedical.com domain is listed for sale — and Hansen Medical operates as an absorbed business unit within Philips without separate financial reporting.

Name

Hansen Medical

Legal name

Hansen Medical

Website

https://hansenmedical.com

Company type

Private

Founded year

2002

Operating status

Acquired

Headcount range

101–250 employees

Short description

Hansen Medical, founded in 2002 and now a Philips subsidiary, developed the Magellan Robotic System for catheter-based cardiovascular procedures, serving hospitals and cardiovascular care centers performing robotic-assisted PCI and electrophysiology interventions.

Ownership category

akta.pro rank

Product category

Medical Robotics (Cardiovascular Surgical Systems)

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industry

Healthcare & Assistive Robotics (HDAAAIAC)

Keywords

• Robotic surgical systems
• Catheter-based robotics
• Cardiovascular intervention
• Medical robotics manufacturing
• Minimally invasive robotics

Headquarters

HQ city

Mountain View

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Core offering

Hansen Medical designs and manufactures medical robotics for the accurate positioning and control of catheter-based technologies used in cardiovascular procedures. Its flagship offering is the Magellan Robotic System, a robotic-assisted surgical platform that enables physicians to perform minimally invasive interventions such as robotic percutaneous coronary intervention (r-PCI), as well as procedures addressing cardiac arrhythmias including atrial fibrillation, SVT, and ventricular tachycardia.

Product overview

Hansen Medical, a company now part of Philips, offers the Magellan Robotic System as its primary product. The Magellan Robotic System is a robotic-assisted surgical platform designed for cardiovascular procedures, enabling physicians to perform minimally invasive interventions with enhanced precision and control. The company specializes in developing robotic systems for medical procedures, particularly in the cardiovascular domain.

Differentiator

Problem solved

Functional benefit

Brands

• Magellan Robotic System: Robotic system for cardiovascular procedures developed by Hansen Medical.

Products and services

• Magellan Robotic System A robotic-assisted surgical system used for cardiovascular procedures, including robotic percutaneous coronary intervention (r-PCI) and vascular interventions. The system enables physicians to perform precise, minimally invasive cardiovascular interventions with enhanced catheter control and navigation, addressing conditions such as cardiac arrhythmias (atrial fibrillation, SVT, ventricular tachycardia). It is designed for hospitals and cardiovascular care centers performing complex cardiac procedures.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• PhilipscoreOthers · 1 January 2019Hansen Medical was acquired by Philips and became part of the Philips Health Systems portfolio. The Magellan Robotic System is now integrated into Philips' broader medical technology offerings for cardiovascular care. Philips has continued to operate the technology for robotic-assisted cardiovascular procedures.

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Stryker (Mako): Operates the Mako robotic-assisted surgery platform for orthopedics, illustrating how a large medtech scales robotic capital equipment. Comparable as a model for how Magellan's installed base could be commercialized within Philips.
• Medtronic: Developer of the Hugo robotic-assisted surgery system and a leading cardiovascular device manufacturer. Comparable as a large incumbent with both a surgical robotics franchise and significant cath-lab presence adjacent to Hansen's market.
• Siemens Healthineers: Owner of Corindus and a global leader in interventional imaging and cath-lab solutions. Comparable as the parent of Hansen's main direct competitor and as a peer in image-guided cardiovascular intervention.
• Intuitive Surgical: Dominant surgical robotics platform (da Vinci) expanding into adjacent catheter and endoluminal applications. Broad incumbent in medical robotics with vastly greater scale, capital, and clinical evidence infrastructure than Hansen.
• Johnson & Johnson (Ethicon / Auris): Owner of the Auris Health (Monarch) and Ottava robotic surgery platforms, with strong presence in interventional cardiology through Biosense Webster. Comparable as a deep-pocketed medtech with overlapping surgical-robotics and EP ambitions.

Direct peers

• Stereotaxis: Stereotaxis develops robotic magnetic navigation systems for cardiac catheter ablation and electrophysiology procedures. Direct competitor to Hansen's robotic catheter platform in the EP/cath-lab robotics niche.
• Robocath: French company developing the R-One robotic system for coronary angioplasty. Direct competitor in robotic PCI with CE mark and emerging European adoption — closely comparable to Magellan's clinical positioning.
• Corindus (Siemens Healthineers): Corindus develops the CorPath GRX robotic system for percutaneous coronary and vascular interventions. Most direct competitor to Hansen's Magellan in robotic PCI, now backed by Siemens Healthineers' global distribution.

Others

• Philips (parent context): Hansen's parent company and operator of the Magellan franchise. Listed as a contextual peer to characterize the scale, distribution, and imaging-integration context in which Magellan competes rather than as an external comparable.

Emerging players

• Catheter Precision: Develops cardiac catheter navigation and ablation technologies including the ViewFlex ICE catheter and electrophysiology tools. Comparable in targeting interventional cardiology and EP workflows where Hansen/Magellan operates.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/hansenmedical
• Facebookfacebook.com/498759616812789
• LinkedInlinkedin.com/company/hansen-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds7 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hansen Medical